BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 8005001)

  • 21. Prostate cancer chemoprevention: Strategies for designing efficient clinical trials.
    Lieberman R
    Urology; 2001 Apr; 57(4 Suppl 1):224-9. PubMed ID: 11295633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of prostate cancer.
    Kucuk O
    Cancer Metastasis Rev; 2002; 21(2):111-24. PubMed ID: 12465750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of phase III clinical trials of prostate cancer chemoprevention.
    Thorpe JF; Jain S; Marczylo TH; Gescher AJ; Steward WP; Mellon JK
    Ann R Coll Surg Engl; 2007 Apr; 89(3):207-11. PubMed ID: 17394699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trials point to complexities of chemoprevention for cancer.
    Hampton T
    JAMA; 2005 Jul; 294(1):29-31. PubMed ID: 15998876
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolio.
    Parnes HL; House MG; Kagan J; Kausal DJ; Lieberman R
    J Urol; 2004 Feb; 171(2 Pt 2):S68-74; discussion S75. PubMed ID: 14713758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamide.
    Singletary E; Lieberman R; Atkinson N; Sneige N; Sahin A; Tolley S; Colchin M; Bevers T; Stelling C; Fornage B; Fritsche H; Hittelman W; Kelloff G; Lippman SM
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1087-90. PubMed ID: 11045792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is There a Future for Chemoprevention of Prostate Cancer?
    Bosland MC
    Cancer Prev Res (Phila); 2016 Aug; 9(8):642-7. PubMed ID: 27099271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer.
    Decensi A; Costa A
    Eur J Cancer; 2000 Apr; 36(6):694-709. PubMed ID: 10762741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate cancer prevention agent development: Criteria and pipeline for candidate chemoprevention agents.
    Nelson WG; Wilding G
    Urology; 2001 Apr; 57(4 Suppl 1):56-63. PubMed ID: 11295596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoprevention of breast cancer: the Italian experience.
    Decensi A; Bonanni B; Guerrieri-Gonzaga A; Torrisi R; Manetti L; Robertson C; De Palo G; Formelli F; Costa A; Veronesi U
    J Cell Biochem Suppl; 2000; 34():84-96. PubMed ID: 10762020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovary.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1995; 23():1-9. PubMed ID: 8747372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoprevention. Strategies for the control of cancer.
    Lippman SM; Benner SE; Hong WK
    Cancer; 1993 Aug; 72(3 Suppl):984-90. PubMed ID: 8334674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention and early detection clinical trials: opportunities for primary care providers and their patients.
    Ford LG; Minasian LM; McCaskill-Stevens W; Pisano ED; Sullivan D; Smith RA
    CA Cancer J Clin; 2003; 53(2):82-101. PubMed ID: 12691266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer.
    Kelloff GJ; Lieberman R; Steele VE; Boone CW; Lubet RA; Kopelovich L; Malone WA; Crowell JA; Higley HR; Sigman CC
    Urology; 2001 Apr; 57(4 Suppl 1):46-51. PubMed ID: 11295594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practice.
    Canby-Hagino ED; Thompson IM
    Nat Clin Pract Oncol; 2005 May; 2(5):255-61. PubMed ID: 16264961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoprevention: will it work?
    Mettlin C
    Int J Cancer; 1997; Suppl 10():18-21. PubMed ID: 9209015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer chemoprevention.
    Brenner DE
    Crit Rev Oncol Hematol; 2000 Mar; 33(3):155-6. PubMed ID: 10789489
    [No Abstract]   [Full Text] [Related]  

  • 38. Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture.
    Lippman SM; Lee JJ
    Cancer Res; 2006 Mar; 66(6):2893-903. PubMed ID: 16540634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoprevention of lung cancer.
    Hong WK
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):135-41. PubMed ID: 10550838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress in cancer chemoprevention.
    Kelloff GJ; Crowell JA; Steele VE; Lubet RA; Boone CW; Malone WA; Hawk ET; Lieberman R; Lawrence JA; Kopelovich L; Ali I; Viner JL; Sigman CC
    Ann N Y Acad Sci; 1999; 889():1-13. PubMed ID: 10668477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.